Market Overview

UPDATE: Johnson & Johnson Posts Upbeat Q2 Profit

Related JNJ
Ebola Vaccine Contenders
Procter & Gamble Co Shares Lower Following Management Change
Making Money With Charles Payne: 10/14/14 (Fox Business)

Johnson & Johnson (NYSE: JNJ) reported a rise in its second-quarter profit.

Johnson & Johnson's quarterly profit surged to $3.83 billion, or $1.33 per share, versus $1.41 billion, or $0.50 per share, in the year-ago period. Its adjusted earnings came in at $1.48 per share.

Its revenue surged 8.5% to $17.88 billion from $16.48 billion. However, analysts were projecting earnings of $1.39 per share on revenue of $17.7 billion.

Johnson & Johnson projects adjusted full-year earnings of $5.40 to $5.47 per share. However, analysts were projecting earnings of $5.41 per share.

Johnson & Johnson shares gained 0.88% to $91.20 in pre-market trading.

Posted-In: profitEarnings News Guidance

 

Related Articles (JNJ)

Around the Web, We're Loving...

Get Benzinga's Newsletters